Synpromics' products vastly improve upon the natural promoters on which the entire biotech industry currently relies to regulate genes. The company's technology allows it to leverage a cell's transcriptome, or gene expression profile, to design and construct synthetic promoters that are only active in a specific cell type that is subject to a particular condition of interest.
This has not been possible until now and consequently there is enormous potential for Synpromics to use its technology to transform the entire Biotech sector. The company is currently active in a number of diverse fields, including: Cell & Gene Therapy, Biologics Bioprocessing, Industrial Biotechnology, Agricultural Biotechnology and Cell-Based Assays. Additionally, we are open to applying our technology to new disciplines and welcome enquiries from organisations wishing to improve gene expression in their model system.